{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "RHI",
  "name": "Robert Half Inc.",
  "url": "https://orbyd.app/dossiers/RHI/",
  "json_url": "https://orbyd.app/dossiers/RHI.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "White-collar staffing in secular decline: Q2 EPS collapsed to $0.26 (2026-07-23) as AI automation and a frozen hiring market gut permanent-placement demand. The >5% dividend yield reads as a value-trap signal rather than a floor. No accelerating long narrative; a cyclical bounce needs labor data to turn first.",
  "invalidation_trigger": "A weekly close below $36 confirms the secular staffing downtrend and kills any cyclical-bounce thesis, opening a slide toward Goldman's $29 Sell target; a dividend cut would seal the value-trap read.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "cyclical-industrials",
    "ai-datacenter-infrastructure",
    "managed-care-health-services"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Theme seed 'managed-care-health-services' is a mis-classification RHI is professional/finance-accounting staffing plus Protiviti consulting; corrected themes applied.",
    "Q2 2026 reported 2026-07-23 (EPS $0.26 inline, revenue $1.336B beat). Next earnings ~2026-10-22 est. Q2 binary is behind the tape.",
    "Analyst PT spread is unusually wide: Goldman Sell $29 (2026-07-24) vs Truist Buy $50 (2026-07-22) a contested cyclical bottom.",
    "Not a momentum long. Monitor labor-market prints (BLS jobs ~2026-08-07 est., JOLTS) and any dividend-declaration change as the real swing factors before considering a cyclical-recovery entry.",
    "Earnings blackout: none imminent Q2 already printed; next print is mid/late-October."
  ],
  "body_markdown": "## Current Thesis\nRobert Half is a cyclical white-collar staffing incumbent stuck in a multi-quarter earnings recession. Q2 2026 (reported 2026-07-23): EPS $0.26 inline, revenue $1.336B a whisker over the $1.322B estimate. Q3 guide is EPS $0.43–$0.53 vs $0.47 consensus and sales $1.310B–$1.410B a midpoint roughly in line but a range wide enough to signal management has little demand visibility. The stock still sold off 2026-07-24 despite the revenue beat. Goldman reiterated Sell (PT lifted $26→$29 on 2026-07-24) while Truist held Buy (PT $50, 2026-07-22) a ~72% target spread that marks a genuinely contested, unresolved cyclical bottom. The narrative here is breaking, not accelerating. This is a value-trap watch item, not the kind of momentum long this playbook exists to catch.\n\n## Bull Case\n- Top-line bleed is slowing: Q2 revenue $1.336B edged past the $1.322B estimate (2026-07-23), the first hint the sequential decline is flattening.\n- Q3 guide midpoint (~$0.48 EPS, ~$1.36B sales) implies EPS steps up off the depressed $0.26 Q2 trough.\n- Protiviti (the risk/consulting arm) is the higher-margin, less-cyclical engine and a structural offset to contract-staffing softness.\n- Truist Buy, PT $50 (2026-07-22) prices the cyclical-recovery upside if white-collar hiring thaws into 2027.\n- A >5% dividend yield plus a historically net-cash balance sheet offers a paid-to-wait carry conditional on the payout holding.\n- Staffing volumes are an early-cycle mover; a Fed easing path has historically front-run a rebound in placement demand.\n\n## Bear Case\n- EPS has more than halved: $0.26 in Q2 against the >$1 quarterly run-rate of the last upcycle earnings power is structurally impaired.\n- AI automation is a secular, not cyclical, headwind and hits exactly the finance, accounting, admin, and contract-tech roles RHI places.\n- Goldman reiterated Sell twice this month (PT $26 on 2026-07-14, raised to $29 on 2026-07-24) the bear target still sits ~28% under where high-yield screens place the stock.\n- The 2026-07-24 drop came on a revenue beat, meaning the tape is discounting both the guide and the quality of any recovery.\n- The >5% yield is a value-trap signal: it is elevated because price collapsed, and dividend-cut risk rises if the earnings recession runs into 2027.\n- A wide Q3 guide ($0.43–$0.53) is what low-visibility looks like, and low-visibility guides tend to precede downward revisions.\n\n## Setup & Price Structure\n- Secular downtrend intact; the tape has rolled over across multiple quarters the opposite of an accelerating-narrative setup.\n- The 2026-07-16 one-day pop (RHI tagged in the \"moving higher\" group) faded straight into the 2026-07-24 post-earnings drop a failed bounce inside a downtrend.\n- Analyst band runs $29 (Goldman, bear) to $50 (Truist, bull); price sits in the lower half, pulled gravitationally toward the Sell target near $29.\n- No base, no higher-low sequence, no breakout retest nothing a momentum entry keys on. A long at these levels is bottom-fishing a falling knife.\n- Beginner-trap read: high dividend yield plus a \"cheap\" optical multiple plus a beaten-down price is the classic value-trap quadrant, not a setup.\n\n## Catalyst Calendar (next 30 days)\n\n- ~2026-08-07 (est.): monthly BLS jobs report; JOLTS follows mid-month labor-market prints are the real swing factor for a staffing name, and further white-collar softening pressures the stock.\n- ~2026-08 (est.): quarterly dividend declaration / ex-dividend window (RHI has historically declared around mid-August); any payout change is the tell on balance-sheet stress a cut confirms the bear case.\n- No dated company-specific momentum catalyst inside the 30-day window. Next binary is Q3 2026 earnings, ~2026-10-22 (est.), well outside it.\n\n## Elapsed catalysts\n\n- 2026-07-23: Q2 2026 earnings ALREADY REPORTED (EPS $0.26, revenue $1.336B). The binary is behind the tape. _(passed 3d ago)_\n\n## What Would Change Our Mind\n- Two consecutive quarters of sequential revenue AND EPS growth, confirming a cyclical trough that would justify a cyclical-recovery long.\n- A weekly close back above ~$50 on expanding volume, reclaiming the Truist target and breaking the downtrend a structural inflection worth chasing.\n- Evidence Protiviti is scaling fast enough to offset staffing declines (segment growth north of ~15% in a print).\n- A labor-market re-acceleration JOLTS white-collar openings turning up the leading indicator for placement volume.\n\n## Correlation Notes\n- Moves with staffing/labor peers: MAN (ManpowerGroup, tagged higher alongside RHI on 2026-07-16), plus ASGN, KFRC, HSII, RHI-adjacent professional-staffing names. This is a sector cyclical bet rather than an idiosyncratic story.\n- Inversely exposed to the AI-labor-displacement narrative the automation story that lifts AI names is a structural drag on white-collar placement demand.\n- Rate-sensitive: a Fed easing cycle that revives corporate hiring is the macro key; a \"higher-for-longer\" regime extends the earnings recession.\n- The seeded theme \"managed-care-health-services\" is a classification error no read-through to managed-care or health names; the correct peer set is professional staffing.",
  "first_seen": "2026-07-23",
  "last_analyzed": "2026-07-25T07:28:41+00:00",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}